BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AGAH - ECPv5.16.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AGAH
X-ORIGINAL-URL:https://dev.agah.eu
X-WR-CALDESC:Events for AGAH
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20220916T160000
DTEND;TZID=Europe/Berlin:20220916T173000
DTSTAMP:20260929T015842
CREATED:20220811T163806Z
LAST-MODIFIED:20220912T153240Z
UID:5684-1663344000-1663349400@dev.agah.eu
SUMMARY:2nd EUFEMEDs Innovation Club Webinar
DESCRIPTION:Submitting an application for a CTA and what do sponsors from outside the EU need to consider \n\n\n\n	INFORMATION \n2023 – When the CTR will be in force for all – Let’s be prepared \nEUFEMED’s Innovation Club is inviting you to the second Webinar on prepara-tion for the new regulatory environment under the Clinical Trial Regulation \nUnder the Clinical Trial Regulation the clinical trial authorisation application has to occur in a new process: a “Single Dossier” has to be submitted to the “Single Portal” of CTIS (EU Clinical Trial Information System). Sponsors have to respond within a few days to deficiencies in the validation process and to “Requests for Further Information”. Access to CTIS\, the dossier preparation and submission\, and the decision making process on further information to be submitted require a very detailed planning and agreement between sponsor and clinical trial unit/CRO on responsibilities and oversight. In this webinar we will discuss strategies and first experiences on efficient collaboration between international sponsor organisati-ons and early phase service providers. \nATTENDANCE FEES (excl. VAT): \n\nMember ticket: € 30.00\nNon-member ticket: € 60.00\n\nMember ticets are available for members of: Association of Human Pharmacology in the Pharmaceutical Industry (AHPPI - UK)\, Healixia (Belgium)\, Association Française de Pharmacologie Translationnelle (AFPT – France)\, Association for Ap-plied Human Pharmacology (AGAH - Germany)\, Associatie van Contract Research Organisaties in Nederland (ACRON - Netherlands) \n  \nThis is the second of four 2022 EUFEMED webinars. If you have already registered for all four webinars\, you do not have to register seperately for this one. Here are the next two webinars: \n\n4 November 2022(16:00-17:30 CET): Reporting obligations under the Clinical trial Regulation: SUSARS\, Serious Breaches\, Summary of Trial Results and Lay Summary of trial results via CTIS \n9 December 2022 (16:00 - 17:30 CET): Christmas Lecture: Latest innovations in early medicines development\n\n  \n\n\n\n\n	PROGRAM AND REGISTRATION \nhttps://courses.2mpact.be/eufemed-2022-1609 \n  \n\n\n\n\n	CONTACT \nResponsible for the program and performance \nEUFEMED\nRue de l’industrie 4\n1000 Brussels\nBELGIUM \ninfo@eufemed.eu\nwww.eufemed.eu \n 
URL:https://dev.agah.eu/event/2nd-eufemeds-innovation-club-webinar/
LOCATION:Webinar
CATEGORIES:Termin,Training
ORGANIZER;CN="EUFEMED":MAILTO:info@eufemed.eu
END:VEVENT
END:VCALENDAR